Location History:
- Schnectady, NY (US) (2004)
- Schenectady, NY (US) (2004 - 2014)
Company Filing History:
Years Active: 2004-2014
Title: The Innovative Contributions of Russell Joseph Deorazio
Introduction
Russell Joseph Deorazio is a notable inventor based in Schenectady, NY (US). He holds a total of four patents, showcasing his significant contributions to the field of pharmaceuticals and medical treatments. His work primarily focuses on developing compounds that have therapeutic applications in various medical conditions.
Latest Patents
One of his latest patents is for pyrazole derivatives as ERK inhibitors. This invention describes substituted pyrazole derivatives of Formula I and methods of making and using these compounds. The compounds have utility in treating conditions or diseases where modification of the activity of ERK would yield a positive therapeutic outcome, such as various cancers, psoriasis, and actinic keratosis. Another significant patent involves cyclohexylamine derivatives as subtype selective NMDA receptor antagonists. This patent describes compounds of Formula I and Formula II, along with their pharmaceutically acceptable salts. These compounds are antagonists of NMDA receptor channel complexes, which are useful for treating cerebral vascular disorders, including cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.
Career Highlights
Throughout his career, Russell has worked with prominent companies such as Warner-Lambert Company and Kinentia Biosciences LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and the development of new therapeutic agents.
Collaborations
Russell has collaborated with several professionals in his field, including Sham Shridhar Nikam and Ian Leslie Scott. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Russell Joseph Deorazio's innovative work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of therapeutic needs and a dedication to improving patient outcomes.